Line 344:
Line 344:
==Additional Information==
==Additional Information==
−
None
+
This disease is <u>defined/characterized</u> as detailed below:
+
+
+
The <u>epidemiology/prevalence</u> of this disease is detailed below:
+
+
+
The <u>clinical features</u> of this disease are detailed below:
+
+
Signs and symptoms -
+
+
Laboratory findings -
+
+
The <u>sites of involvement</u> of this disease are detailed below:
+
+
+
The <u>morphologic features</u> of this disease are detailed below:
+
+
+
The <u>immunophenotype</u> of this disease is detailed below:
+
+
Positive (universal) -
+
+
Positive (majority) -
+
+
Positive (subset) -
+
+
Negative (universal) -
+
+
Negative (subset) –
==Links==
==Links==